Patents by Inventor Wolfgang Rettig

Wolfgang Rettig has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Isolated proteins containing portions of FAP? and other proteins
    Patent number: 6846910
    Abstract: The invention involves dimeric forms of the protein known as fibroblast activation protein alpha, or “FAP?” and its uses.
    Type: Grant
    Filed: March 10, 1999
    Date of Patent: January 25, 2005
    Assignees: Ludwig Institute for Cancer Research, Boehringer Ingelheim International GmbH
    Inventors: Rainer Zimmermann, John E. Park, Wolfgang Rettig, Lloyd J. Old
  • ISOLATED PROTEINS CONTAINING PORTIONS OF FAPALPHA AND OTHER PROTEINS
    Publication number: 20020034789
    Abstract: The invention involves dimeric forms of the protein known as fibroblast activation protein alpha, or “FAP&agr;” and its uses.
    Type: Application
    Filed: March 10, 1999
    Publication date: March 21, 2002
    Inventors: RAINER ZIMMERMANN, JOHN E. PARK, WOLFGANG RETTIG, LLOYD J. OLD
  • Isolated dimeric fibroblast activation protein .alpha., and uses thereof
    Patent number: 5965373
    Abstract: The invention involves dimeric forms of the protein known as fibroblast activation protein alpha, or "FAP.alpha." and its uses.
    Type: Grant
    Filed: October 1, 1997
    Date of Patent: October 12, 1999
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Rainer Zimmermann, John E. Park, Wolfgang Rettig, Lloyd J. Old
  • Isolated dimeric fibroblast activation protein alpha, and uses thereof
    Patent number: 5767242
    Abstract: The invention involves dimeric forms of the protein known as fibroblast activation protein alpha, or "FAP.alpha." and its uses.
    Type: Grant
    Filed: March 18, 1996
    Date of Patent: June 16, 1998
    Assignees: Boehringer Ingelheim Int'l GmbH, Ludwig Institute For Cancer Research
    Inventors: Rainer Zimmermann, John E. Park, Wolfgang Rettig, Lloyd J. Old
  • Monoclonal antibodies to human lung cancers and method
    Patent number: 4865998
    Abstract: A panel of monoclonal antibodies produced from normal human lung fibroblasts and human lung tumors as immunogen is used to diagnose the presence of lung tumors and differentiate between those which are benign and those which are cancerous.
    Type: Grant
    Filed: August 10, 1987
    Date of Patent: September 12, 1989
    Assignee: Sloan-Kettering Institute for Cancer Research
    Inventors: Hans-Joachim Feickert, Wolfgang Rettig, Karen Chorney, Carlos Cordon-Cardo, Myron R. Melamed, Kenneth O. Lloyd, Herbert F. Oettgen, Lloyd J. Old, Bernd Anger
  • Monoclonal antibodies to cell surface antigens of human teratocarcinomas
    Patent number: 4762800
    Abstract: Antibody-producing hybridoma cell lines made by fusion of NS/1 cells with spleen cells of mice after immunization with human teratocarcinoma cells are presented. Monoclonal antibodies from these cell lines recognize the K4, K2 and P12 antigenic systems and are thus useful in detecting and differentiating between normal and cancerous cells. These monoclonal antibodies are especially useful in pathologic analysis of human tumors, especially teratocarcinomas.
    Type: Grant
    Filed: April 26, 1984
    Date of Patent: August 9, 1988
    Assignee: Sloan-Kettering Institute for Cancer Research
    Inventors: Wolfgang Rettig, Carolos Cordon-Cardo, Herbert F. Oettgen, Lloyd J. Old, Kenneth O. Lloyd, Jennifer Ng